Switching from vitamin K antagonists to direct oral anticoagulants in non-valvular atrial fibrillation patients: Does low time in therapeutic range affect persistence?

Myrthe M A Toorop Qingui ChenMarieke J H A KruipFelix J M van der MeerMelchior C NiermanLaura FaberLies GoedeSuzanne C Cannegieter Willem M Lijfering

Published in: Journal of thrombosis and haemostasis : JTH (2021)

NVAF patients switching from VKA to DOAC due to a low pre-switch TTR saw a worse persistence pattern to DOAC after the switch compared to patients with a high pre-switch TTR.

Keyphrases

direct oral anticoagulants
atrial fibrillation
end stage renal disease
venous thromboembolism
ejection fraction
chronic kidney disease
heart failure
oral anticoagulants
patient reported outcomes
left atrial
patient reported
acute coronary syndrome
mitral valve